This inventor holds 1 USPTO granted patent. Top assignee: Rapt Therapeutics, Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: The Innovative Contributions of William Yew-Wai Ho
Introduction
William Yew-Wai Ho is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic methods. His work focuses on addressing the challenges posed by Epstein Bar virus (EBV) positive cancers and malignancies.
Latest Patents
William Yew-Wai Ho holds a patent for anticancer agents. The patent discloses therapeutic methods of administering compounds that modulate the C–C chemokine receptor type 4 (CCR4) for the treatment of EBV positive cancers and malignancies. This innovative approach has the potential to improve treatment outcomes for patients suffering from these conditions.
Career Highlights
Ho is currently associated with Rapt Therapeutics, Inc., where he continues to advance his research in cancer therapeutics. His work at the company reflects his commitment to developing effective treatments that can make a difference in the lives of patients.
Collaborations
Throughout his career, William has collaborated with esteemed colleagues such as Gene Cutler and Paul D. Kassner. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
William Yew-Wai Ho's contributions to cancer treatment through his innovative patent and collaborative efforts highlight his dedication to improving patient care. His work exemplifies the impact of innovation in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile